【drug-news】H5N1疫苗可抵御禽流感病毒
这个帖子发布于 18 年零 252 天前，其中的信息可能已发生改变或有所发展。
http://www.forbes.com/markets/feeds/afx/2006/10/18/afx3100923.html
Sanofi says H5N1 vaccine protects against recent bird flu variants
10.18.2006, 12:05 PM
PARIS (AFX) - Sanofi-Aventis' vaccines unit Sanofi Pasteur said tests show the vaccine it is developing in response to the H5N1 bird flu virus also protects against recent variations of the virus not covered by the original formulation.
In May the prototype drug was found has been found to be safe and effective in initial tests on several hundred volunteers.
The new data 'show the potential for a pre-pandemic vaccine to offer broad protection by inducing antibodies that neutralize H5N1 from more recent circulating viruses,' the group said in a statement today.
'Vaccinated volunteers developed serum antibodies that were able to neutralize diverse H5N1 viruses... (that) have caused human infections in several European countries in 2005 and 2006, and continue to cause infections in parts of South East Asia,' the group said.
'These new data reinforce conclusions of the Sanofi Pasteur phase I study published in May 2006,' it added.
paris@afxnews.com
mrg/abr
COPYRIGHT
Copyright AFX News Limited 2006. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
Neither the Subscriber nor AFX News warrants the completeness or accuracy of the Service or the suitability of the Service as a trading aid and neither accepts any liability for losses howsoever incurred. The content on this site, including news, quotes, data and other information, is provided by AFX News and its third party content providers for your personal information only, and neither AFX News nor its third party content providers shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon.
Sanofi says H5N1 vaccine protects against recent bird flu variants
10.18.2006, 12:05 PM
PARIS (AFX) - Sanofi-Aventis' vaccines unit Sanofi Pasteur said tests show the vaccine it is developing in response to the H5N1 bird flu virus also protects against recent variations of the virus not covered by the original formulation.
In May the prototype drug was found has been found to be safe and effective in initial tests on several hundred volunteers.
The new data 'show the potential for a pre-pandemic vaccine to offer broad protection by inducing antibodies that neutralize H5N1 from more recent circulating viruses,' the group said in a statement today.
'Vaccinated volunteers developed serum antibodies that were able to neutralize diverse H5N1 viruses... (that) have caused human infections in several European countries in 2005 and 2006, and continue to cause infections in parts of South East Asia,' the group said.
'These new data reinforce conclusions of the Sanofi Pasteur phase I study published in May 2006,' it added.
paris@afxnews.com
mrg/abr
COPYRIGHT
Copyright AFX News Limited 2006. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
Neither the Subscriber nor AFX News warrants the completeness or accuracy of the Service or the suitability of the Service as a trading aid and neither accepts any liability for losses howsoever incurred. The content on this site, including news, quotes, data and other information, is provided by AFX News and its third party content providers for your personal information only, and neither AFX News nor its third party content providers shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon.
